Injectable matrices and scaffolds for drug delivery in tissue engineering.
By J. Kretlow, L. Klouda, A. Mikos. Advanced Drug Delivery Reviews, 2007
601 citations recorded by the source corpus.
Subfields: Biomaterials, Biomedical Engineering, Pharmaceutical Science
View Paper: https://www.semanticscholar.org/paper/4963c00df2fcf8b49e0c31275de5698712ce20c4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
In Biomedical Engineering
In Pharmaceutical Science
Citations in the corpus
- Engineering hydrogels as extracellular matrix mimics (2010, unknown): “Various formulations of hydrogel materials with known mechanical, physical and chemical properties can be prepared to construct drug-delivery vehicles with finely tuned drug release kinetics [41,42,44,197,198].”
- Controlled drug delivery in tissue engineering. (2008, background): “Thus, it has been soon realized that by integrating controlled release strategies within scaffoldingmaterials may lead to novel multifunctional platforms able to control and guide the tissue regeneration process [18–22].”
- Bioactive Modification of Poly(ethylene glycol) Hydrogels for Tissue Engineering (2010, background): “PEG hydrogels are not naturally degradable, but can be altered to enhance degradation by incorporating degradable segments, such as polyester [29e31], poly(propylene fumarate) (PPF) [32,33], acetal [34] and disulfide [35].”
- Thermoresponsive Polymers for Biomedical Applications (2011, background): “It aims to regenerate or replace biological damaged or diseased tissue or generate replacement organs for a wide range of medical conditions such as heart diseases, diabetes, cirrohosis, osteoarthritis, spinal cord injury and disfiguration [11,50-60].”
- Chitosan—A versatile semi-synthetic polymer in biomedical applications (2011, background): “pplication is being used in a wide range of biomedical nd pharmaceutical applications [176,177].”
- Chitosan-based hydrogels for controlled, localized drug delivery. (2010, background): “These materials can be injected into the body as a liquid, forming a gel in situ where the body temperature is above the LCST, offering the potential to serve as carrier matrices for awide rangeofbiomedical andpharmaceutical applications [24,73].”